| (+)-catechin | multiple interactions | ISO | RGD:1550761 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL4 mRNA | CTD | PMID:16806235 |
| (-)-anisomycin | decreases expression | EXP | | 6480464 | Anisomycin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL4 mRNA]]; more ... | CTD | PMID:16321392 |
| 1,3-benzothiazole-2-thiol | increases secretion | EXP | | 6480464 | captax results in increased secretion of CCL4 protein | CTD | PMID:16314067 |
| 1,4-benzoquinone | increases expression | EXP | | 6480464 | benzoquinone results in increased expression of CCL4 protein | CTD | PMID:17572062 |
| 1,4-phenylenediamine | increases expression | EXP | | 6480464 | 4-phenylenediamine results in increased expression of CCL4 mRNA | CTD | PMID:20713136 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CCL4 protein; more ... | CTD | PMID:16314067 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CCL4 mRNA | CTD | PMID:15585374 more ... |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:1550761 | 6480464 | Dinitrochlorobenzene results in increased expression of CCL4 mRNA | CTD | PMID:19647056 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CCL4 mRNA | CTD | PMID:16314067 PMID:15585374 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CCL4 mRNA | CTD | PMID:15585374 PMID:16314067 |
| 1-chloro-2,4-dinitrobenzene | increases secretion | EXP | | 6480464 | Dinitrochlorobenzene results in increased secretion of CCL4 protein | CTD | PMID:16314067 |
| 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | RGD:1550761 | 6480464 | Dinitrofluorobenzene results in increased expression of CCL4 mRNA | CTD | PMID:15719370 |
| 2,4-D | increases expression | ISO | RGD:1550761 | 6480464 | 2,4-Dichlorophenoxyacetic Acid results in increased expression of CCL4 protein | CTD | PMID:19467290 |
| 2,6-dichloroindophenol | multiple interactions | EXP | | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CCL4 mRNA | CTD | PMID:21034357 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | EXP | | 6480464 | Oxazolone results in increased expression of CCL4 mRNA | CTD | PMID:15585374 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:1550761 | 6480464 | Oxazolone results in increased expression of CCL4 mRNA | CTD | PMID:19647056 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1550761 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CCL4 mRNA | CTD | PMID:19191707 |
| 4-nitroquinoline N-oxide | increases expression | ISO | RGD:1550761 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of CCL4 mRNA | CTD | PMID:22561872 |
| acrylamide | decreases expression | ISO | RGD:1550761 | 6480464 | Acrylamide analog results in decreased expression of CCL4 protein; more ... | CTD | PMID:18287786 |
| alclometasone dipropionate | increases expression | EXP | | 6480464 | alclometasone dipropionate results in increased expression of CCL4 protein | CTD | PMID:20116850 |
| alexidine | decreases expression | EXP | | 6480464 | alexidine results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL4 mRNA | CTD | PMID:19828696 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL4 mRNA | CTD | PMID:15498508 PMID:19828696 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL4 mRNA | CTD | PMID:19828696 PMID:15498508 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL4 protein; more ... | CTD | PMID:19828696 |
| aluminium hydroxide | increases secretion | EXP | | 6480464 | Aluminum Hydroxide results in increased secretion of CCL4 protein | CTD | PMID:18390722 |
| ammonium chloride | affects expression | ISO | RGD:620441 | 6480464 | Ammonium Chloride affects the expression of CCL4 mRNA | CTD | PMID:16483693 |
| antimycin A | decreases expression | EXP | | 6480464 | Antimycin A results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of CCL4 mRNA | CTD | PMID:16835338 |
| arsenite(3-) | affects expression | EXP | | 6480464 | arsenite affects the expression of CCL4 mRNA | CTD | PMID:22959463 |
| Bandrowski's base | affects expression | EXP | | 6480464 | Bandrowski's base affects the expression of CCL4 mRNA | CTD | PMID:18202158 |
| beclomethasone | increases expression | EXP | | 6480464 | Beclomethasone results in increased expression of CCL4 protein | CTD | PMID:20116850 |
| benzene | decreases expression | ISO | RGD:1550761 | 6480464 | Benzene results in decreased expression of CCL4 mRNA | CTD | PMID:15120971 PMID:15122651 |
| benzene | decreases expression | ISO | RGD:1550761 | 6480464 | Benzene results in decreased expression of CCL4 mRNA | CTD | PMID:15122651 PMID:15120971 |
| benzene-1,2,4-triol | affects expression | EXP | | 6480464 | hydroxyhydroquinone affects the expression of CCL4 protein | CTD | PMID:17572062 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCL4 mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | increases expression | ISO | RGD:1550761 | 6480464 | Benzo(a)pyrene results in increased expression of CCL4 mRNA | CTD | PMID:22228805 |
| beryllium sulfate | increases secretion | EXP | | 6480464 | beryllium sulfate results in increased secretion of CCL4 mRNA | CTD | PMID:16314022 |
| betamethasone | increases expression | EXP | | 6480464 | Betamethasone results in increased expression of CCL4 protein | CTD | PMID:20116850 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1550761 | 6480464 | Mustard Gas results in increased expression of CCL4 mRNA | CTD | PMID:15674843 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of CCL4 protein | CTD | PMID:17720292 |
| budesonide | increases expression | EXP | | 6480464 | Budesonide results in increased expression of CCL4 protein | CTD | PMID:20116850 |
| camptothecin | decreases expression | EXP | | 6480464 | Camptothecin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| catechol | increases expression | EXP | | 6480464 | catechol results in increased expression of CCL4 protein | CTD | PMID:17572062 |
| cefaloridine | decreases expression | ISO | RGD:620441 | 6480464 | Cephaloridine results in decreased expression of CCL4 mRNA | CTD | PMID:18500788 |
| cephaeline | decreases expression | EXP | | 6480464 | cephaelin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| chlorpyrifos | increases expression | ISO | RGD:1550761 | 6480464 | Chlorpyrifos results in increased expression of CCL4 mRNA | CTD | PMID:22515965 |
| choline | multiple interactions | ISO | RGD:1550761 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL4 mRNA | CTD | PMID:20938992 |
| cis-caffeic acid | multiple interactions | ISO | RGD:1550761 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL4 mRNA | CTD | PMID:16806235 |
| cisplatin | decreases expression | ISO | RGD:620441 | 6480464 | Cisplatin results in decreased expression of CCL4 mRNA | CTD | PMID:22023808 |
| cobalt atom | multiple interactions | ISO | RGD:620441 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CCL4 mRNA | CTD | PMID:22198552 |
| cobalt(2+) sulfate | increases secretion | EXP | | 6480464 | cobalt sulfate results in increased secretion of CCL4 protein | CTD | PMID:16314067 |
| cobalt(2+) sulfate | increases expression | EXP | | 6480464 | cobalt sulfate results in increased expression of CCL4 mRNA | CTD | PMID:20713136 |
| cortisol | increases expression | EXP | | 6480464 | Hydrocortisone results in increased expression of CCL4 protein | CTD | PMID:20116850 |
| D-penicillamine | increases expression | ISO | RGD:620441 | 6480464 | Penicillamine results in increased expression of CCL4 mRNA | CTD | PMID:19575532 |
| dasatinib (anhydrous) | decreases expression | EXP | | 6480464 | dasatinib results in decreased expression of CCL4 protein | CTD | PMID:17962511 |
| daunorubicin | decreases expression | EXP | | 6480464 | Daunorubicin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL4 mRNA | CTD | PMID:19828696 |
| digitoxigenin | decreases expression | EXP | | 6480464 | Digitoxigenin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| digoxigenin | decreases expression | EXP | | 6480464 | Digoxigenin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| digoxin | decreases expression | EXP | | 6480464 | Digoxin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| dioxygen | multiple interactions | ISO | RGD:1550761 | 6480464 | SCGB1A1 protein affects the reaction [Oxygen results in increased expression of CCL4 mRNA] | CTD | PMID:10027076 |
| dioxygen | multiple interactions | ISO | RGD:1550761 | 6480464 | [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CCL4 mRNA; more ... | CTD | PMID:22363622 |
| dioxygen | increases expression | ISO | RGD:1550761 | 6480464 | Oxygen results in increased expression of CCL4 mRNA | CTD | PMID:10027076 PMID:22363622 |
| dioxygen | increases expression | ISO | RGD:1550761 | 6480464 | Oxygen results in increased expression of CCL4 mRNA | CTD | PMID:10027076 |
| emetine | decreases expression | EXP | | 6480464 | Emetine results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| ethanol | affects secretion | ISO | RGD:1550761 | 6480464 | Ethanol affects the secretion of CCL4 protein | CTD | PMID:20624996 |
| ethanol | multiple interactions | ISO | RGD:1550761 | 6480464 | Ethanol inhibits the reaction [Poly I-C results in increased expression of CCL4 protein] | CTD | PMID:19500611 |
| eugenol | increases expression | EXP | | 6480464 | Eugenol results in increased expression of CCL4 mRNA | CTD | PMID:15585374 |
| fludrocortisone | increases expression | EXP | | 6480464 | Fludrocortisone results in increased expression of CCL4 protein | CTD | PMID:20116850 |
| folic acid | multiple interactions | ISO | RGD:1550761 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL4 mRNA | CTD | PMID:20938992 |
| furan | increases expression | ISO | RGD:1550761 | 6480464 | furan results in increased expression of CCL4 mRNA | CTD | PMID:20194422 |
| gadodiamide hydrate | increases expression | ISO | RGD:620441 | 6480464 | gadodiamide results in increased expression of CCL4 protein | CTD | PMID:20938346 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of CCL4 mRNA | CTD | PMID:15256057 |
| glutaraldehyde | increases expression | EXP | | 6480464 | Glutaral results in increased expression of CCL4 mRNA | CTD | PMID:20713136 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL4 mRNA | CTD | PMID:17183730 |
| hydrogen chloride | increases expression | ISO | RGD:620441 | 6480464 | Hydrochloric Acid results in increased expression of CCL4 protein; more ... | CTD | PMID:16129981 |
| hydrogen chloride | multiple interactions | ISO | RGD:620441 | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL4 protein]; more ... | CTD | PMID:16129981 |
| hydroquinone | increases expression | EXP | | 6480464 | hydroquinone results in increased expression of CCL4 protein | CTD | PMID:17572062 |
| indole-3-methanol | affects expression | ISO | RGD:620441 | 6480464 | indole-3-carbinol affects the expression of CCL4 mRNA | CTD | PMID:21396975 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL4 protein]]; more ... | CTD | PMID:21913898 |
| ionomycin | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL4 protein | CTD | PMID:17572062 |
| L-methionine | multiple interactions | ISO | RGD:1550761 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL4 mRNA | CTD | PMID:20938992 |
| methionine sulfoximine | decreases expression | EXP | | 6480464 | Methionine Sulfoximine results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CCL4 protein | CTD | PMID:19100307 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CCL4 mRNA | CTD | PMID:17400583 |
| methotrexate | multiple interactions | EXP | | 6480464 | SB 203580 affects the reaction [Methotrexate results in decreased expression of CCL4 protein] | CTD | PMID:19100307 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL4 mRNA]]; more ... | CTD | PMID:16321392 |
| minocycline | decreases expression | EXP | | 6480464 | Minocycline results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| mycophenolic acid | decreases expression | ISO | RGD:1550761 | 6480464 | Mycophenolic Acid results in decreased expression of CCL4 mRNA | CTD | PMID:19818335 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:620441 | 6480464 | Methylnitrosourea results in increased expression of CCL4 mRNA | CTD | PMID:17412507 |
| nickel atom | multiple interactions | ISO | RGD:620441 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CCL4 mRNA | CTD | PMID:22198552 |
| nickel sulfate | increases secretion | EXP | | 6480464 | nickel sulfate results in increased secretion of CCL4 protein | CTD | PMID:16314067 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL4 mRNA | CTD | PMID:12060402 more ... |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL4 mRNA | CTD | PMID:16314067 more ... |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL4 mRNA | CTD | PMID:12060402 more ... |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL4 mRNA | CTD | PMID:16780908 more ... |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL4 mRNA | CTD | PMID:16314067 PMID:16780908 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL4 protein | CTD | PMID:16314067 |
| oxytetracycline | decreases expression | EXP | | 6480464 | Oxytetracycline results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| palmatine | decreases expression | EXP | | 6480464 | palmatine results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| paracetamol | affects expression | ISO | RGD:1550761 | 6480464 | Acetaminophen affects the expression of CCL4 mRNA | CTD | PMID:17562736 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL4 protein | CTD | PMID:17572062 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CCL4 mRNA | CTD | PMID:18958680 |
| phthalic anhydride | increases expression | ISO | RGD:1550761 | 6480464 | phthalic anhydride results in increased expression of CCL4 protein | CTD | PMID:20219652 |
| prednisolone | increases expression | EXP | | 6480464 | Prednisolone results in increased expression of CCL4 protein | CTD | PMID:20116850 |
| propidium | decreases expression | EXP | | 6480464 | Propidium results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL4 protein]]]; more ... | CTD | PMID:21913898 |
| prostaglandin E2 | decreases expression | ISO | RGD:1550761 | 6480464 | Dinoprostone results in decreased expression of CCL4 protein | CTD | PMID:17667525 |
| prostaglandin E2 | decreases expression | EXP | | 6480464 | Dinoprostone results in decreased expression of CCL4 mRNA | CTD | PMID:16303787 |
| puromycin | decreases expression | EXP | | 6480464 | Puromycin results in decreased expression of CCL4 protein | CTD | PMID:20116850 |
| resveratrol | multiple interactions | ISO | RGD:1550761 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL4 mRNA | CTD | PMID:16806235 |
| rosiglitazone | decreases expression | ISO | RGD:620441 | 6480464 | rosiglitazone results in decreased expression of CCL4 mRNA | CTD | PMID:21515302 |
| silicon dioxide | increases expression | ISO | RGD:1550761 | 6480464 | Silicon Dioxide results in increased expression of CCL4 mRNA | CTD | PMID:19073995 |
| simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL4 mRNA]]; more ... | CTD | PMID:16321392 |
| sodium dodecyl sulfate | decreases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of CCL4 mRNA | CTD | PMID:20713136 |
| succimer | multiple interactions | ISO | RGD:1550761 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL4 mRNA | CTD | PMID:21641980 |
| tamibarotene | increases expression | EXP | | 6480464 | Am 80 results in increased expression of CCL4 mRNA; more ... | CTD | PMID:15498508 |
| taurocholic acid | increases expression | ISO | RGD:1550761 | 6480464 | Taurocholic Acid results in increased expression of CCL4 mRNA | CTD | PMID:21224055 |
| titanium dioxide | increases expression | ISO | RGD:1550761 | 6480464 | titanium dioxide results in increased expression of CCL4 mRNA | CTD | PMID:19464567 |
| titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of CCL4 mRNA | CTD | PMID:19695317 |
| titanium dioxide | increases secretion | EXP | | 6480464 | titanium dioxide results in increased secretion of CCL4 protein | CTD | PMID:20005940 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:1550761 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL4 protein | CTD | PMID:20219652 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:1550761 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL4 mRNA | CTD | PMID:19647056 |
| trans-resveratrol | multiple interactions | ISO | RGD:1550761 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL4 mRNA | CTD | PMID:16806235 |
| trimellitic anhydride | increases expression | ISO | RGD:1550761 | 6480464 | trimellitic anhydride results in increased expression of CCL4 protein | CTD | PMID:20219652 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CCL4 mRNA | CTD | PMID:19631733 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CCL4 mRNA | CTD | PMID:20846491 PMID:19631733 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CCL4 mRNA | CTD | PMID:19631733 PMID:20846491 |
| tungsten atom | multiple interactions | ISO | RGD:620441 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CCL4 mRNA | CTD | PMID:22198552 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL4 mRNA | CTD | PMID:17183730 |